The STEP-HFpEF trial was designed to evaluate the effects of treatment on symptoms and physical limitations, exercise function and inflammation, along with body weight, and was, therefore, not powered to assess clinical endpoints such as HF hospitalizations
GLP-1 drugs such as semaglutide are reshaping treatment of obesity, diabetes and cardiovascular disease with broader physiological effects now emerging
Researchers are encouraged to explore its potential synergistic benefits and individual contributions to gain a deeper understanding
A Clear Distinction from Fad Diets What makes semaglutide different from typical weight loss solutions is that it doesnt rely on willpower or unrealistic calorie restrictions
If you are overweight or obese but do not have diabetes, Zepbound is the FDA-approved weight loss alternative
A cortisol detox comprises of methodically targeted biochemical, neurological, and behavioural interventions which resets your stress response system